Transformational therapies demand a new mindsetPharma is moving to a new era of radically new therapies, presenting unexpected and difficult challenges. Such interventions Share XTransformational therapies demand a new mindsethttps://pharmaphorum.com/views-and-analysis/transformational-therapies-demand-a-new-mindset/
The meaning of digital innovation: the pharmaphorum podcastThis instalment of the podcast considers the meaning of digital innovation, both in pharma and outside the industry, Share XThe meaning of digital innovation: the pharmaphorum podcasthttps://pharmaphorum.com/podcast/digital-innovation-edwin-erckens-exeevo/
Health Innovators: Owlstone Medical’s Billy Boyle on breath biopsy technologyIn the latest episode of our Health Innovators series, Paul Tunnah speaks to Billy Boyle, co-founder and CEO Share XHealth Innovators: Owlstone Medical’s Billy Boyle on breath biopsy technologyhttps://pharmaphorum.com/video/health-innovators-billy-boyle-owlstone-medical/
Expediting innovation in the rare disease domainRare diseases affect a fraction of the population – 450 million+ people globally. However, its effects can be Share XExpediting innovation in the rare disease domainhttps://pharmaphorum.com/r-d/views-analysis-r-d/expediting-innovations-in-rare-disease-domain/
Why starting an innovation journey isn’t sexyChugai Pharmaceutical’s UK innovation lead, Martin Ellgood explores the challenges pharma companies face when devising innovation strategies. On Share XWhy starting an innovation journey isn’t sexyhttps://pharmaphorum.com/r-d/views-analysis-r-d/why-starting-an-innovation-journey-isnt-sexy/
Moderna and BioNTech – who are they?Moderna and BioNTech, two rising stars in biotech, were in the limelight this year with their pioneering mRNA Share XModerna and BioNTech – who are they?https://pharmaphorum.com/views-and-analysis/moderna-and-biontech-who-are-they/
Frontiers Health 2020 day oneDigital health innovation conference Frontiers Health kicks off its 2020 edition this week, although the majority of the Share XFrontiers Health 2020 day onehttps://pharmaphorum.com/views-analysis-digital/frontiers-health-2020-day-one/
Deep Dive: Digital Health Innovation 2020Most of the digital health experts we spoke to for this issue of Deep Dive made one thing Share XDeep Dive: Digital Health Innovation 2020https://pharmaphorum.com/views-analysis-digital/deep-dive-digital-health-innovation-2020/
Innovation boosts R&D outlook despite COVID difficulties – reportAyming Group’s second annual International Innovation Barometer (IIB) has said that the international outlook for R&D is “remarkably Share XInnovation boosts R&D outlook despite COVID difficulties – reporthttps://pharmaphorum.com/r-d/views-analysis-r-d/innovation-boosts-rd-outlook-despite-covid-difficulties-report/
